We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What Makes Cabot (CBT) a Solid Investment Option Right Now
Read MoreHide Full Article
Cabot Corporation’s (CBT - Free Report) stock looks promising at the moment. The company’s shares are up around 10% over the past six months. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
Let’s take a look into the factors that make this specialty chemicals and performance materials company an intriguing choice for investors right now.
What Makes CBT an Attractive Pick?
Solid Rank & VGM Score
Cabot has a Zacks Rank #1 (Strong Buy) and a VGM Score of A. Our research shows that stocks with a VGM Score of A or B, combined with a Zacks Rank #1 or 2 (Buy), offer the best investment opportunities for investors.
Estimates Northbound
Earnings estimate revisions have the greatest impact on stock prices. Over the past month, the Zacks Consensus Estimate for Cabot for the current fiscal year has increased around 21.9%. The consensus estimate for the next fiscal has also been revised 15% upward over the same time frame.
Healthy Growth Prospects
The Zacks Consensus Estimate for earnings for the current fiscal for Cabot is currently pegged at $3.29, reflecting an expected year-over-year growth of 58.2%. Moreover, earnings are expected to register a 14.4% growth in the next fiscal year.
Superior Return on Equity (ROE)
ROE is a measure of a company’s efficiency in utilizing shareholder’s funds. ROE for the trailing 12-months for Cabot is 11.7%, above the industry’s level of 9%.
Attractive Valuation
Valuation looks attractive as Cabot’s shares are currently trading at a level that is lower than the industry average, suggesting that the stock still has upside potential.
Going by the EV/EBITDA (Enterprise Value/ Earnings before Interest, Tax, Depreciation and Amortization) multiple, which is often used to value chemical stocks, Cabot is currently trading at trailing 12-month EV/EBITDA multiple of 6.58, cheaper compared with the industry average of 9.66.
Strong Q4 and Upbeat Outlook
Cabot’s adjusted earnings per share of 68 cents for the fourth quarter of fiscal 2020 trounced the Zacks Consensus Estimate of 58 cents. Net sales of $659 million also beat the Zacks Consensus Estimate of $655.6 million. The company saw a rebound in volumes in its Reinforcement Materials segment on a sequential comparison basis in the quarter.
Cabot said that it is encouraged by the pace of recovery in automotive and tire markets as it enters fiscal 2021. The company expects earnings before interest and tax (EBIT) to improve both sequential and year-over-year basis in the first quarter of fiscal 2021.
The company envisions its Reinforcement Materials unit to benefit from improved margins, especially in Asia. It also expects the Performance Chemicals segment to gain in both volumes and product mix from a strengthening automotive market.
Cabot should gain from a recovery in demand from its automotive and tire customers from the pandemic-led slowdown. Moreover, improved pricing in its fumed metal oxides business is expected to support margins in the fiscal first quarter.
The company should also benefit from the acquisition of Shenzhen Sanshun Nano New Materials. The acquisition significantly bolsters the market position and formulation capabilities of Cabot in the high-growth batteries market, especially in China. The buyout is also expected to create opportunities to expand Cabot’s position in the rapidly growing energy storage market.
Other top-ranked stocks worth considering in the basic materials space include BHP Group (BHP - Free Report) , Silvercorp Metals Inc. (SVM - Free Report) and Pretium Resources Inc. .
BHP Group has a projected earnings growth rate of 31.3% for the current fiscal year. The company’s shares have gained around 8% in a year. It currently sports a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Silvercorp has an expected earnings growth rate of 40% for the current fiscal. The company’s shares have gained around 18% in the past year. It currently carries a Zacks Rank #2.
Pretium Resources has an expected earnings growth rate of 25.5% for the current year. The company’s shares have gained around 10% in the past year. It currently carries a Zacks Rank #2.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Image: Bigstock
What Makes Cabot (CBT) a Solid Investment Option Right Now
Cabot Corporation’s (CBT - Free Report) stock looks promising at the moment. The company’s shares are up around 10% over the past six months. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
Let’s take a look into the factors that make this specialty chemicals and performance materials company an intriguing choice for investors right now.
What Makes CBT an Attractive Pick?
Solid Rank & VGM Score
Cabot has a Zacks Rank #1 (Strong Buy) and a VGM Score of A. Our research shows that stocks with a VGM Score of A or B, combined with a Zacks Rank #1 or 2 (Buy), offer the best investment opportunities for investors.
Estimates Northbound
Earnings estimate revisions have the greatest impact on stock prices. Over the past month, the Zacks Consensus Estimate for Cabot for the current fiscal year has increased around 21.9%. The consensus estimate for the next fiscal has also been revised 15% upward over the same time frame.
Healthy Growth Prospects
The Zacks Consensus Estimate for earnings for the current fiscal for Cabot is currently pegged at $3.29, reflecting an expected year-over-year growth of 58.2%. Moreover, earnings are expected to register a 14.4% growth in the next fiscal year.
Superior Return on Equity (ROE)
ROE is a measure of a company’s efficiency in utilizing shareholder’s funds. ROE for the trailing 12-months for Cabot is 11.7%, above the industry’s level of 9%.
Attractive Valuation
Valuation looks attractive as Cabot’s shares are currently trading at a level that is lower than the industry average, suggesting that the stock still has upside potential.
Going by the EV/EBITDA (Enterprise Value/ Earnings before Interest, Tax, Depreciation and Amortization) multiple, which is often used to value chemical stocks, Cabot is currently trading at trailing 12-month EV/EBITDA multiple of 6.58, cheaper compared with the industry average of 9.66.
Strong Q4 and Upbeat Outlook
Cabot’s adjusted earnings per share of 68 cents for the fourth quarter of fiscal 2020 trounced the Zacks Consensus Estimate of 58 cents. Net sales of $659 million also beat the Zacks Consensus Estimate of $655.6 million. The company saw a rebound in volumes in its Reinforcement Materials segment on a sequential comparison basis in the quarter.
Cabot said that it is encouraged by the pace of recovery in automotive and tire markets as it enters fiscal 2021. The company expects earnings before interest and tax (EBIT) to improve both sequential and year-over-year basis in the first quarter of fiscal 2021.
The company envisions its Reinforcement Materials unit to benefit from improved margins, especially in Asia. It also expects the Performance Chemicals segment to gain in both volumes and product mix from a strengthening automotive market.
Cabot should gain from a recovery in demand from its automotive and tire customers from the pandemic-led slowdown. Moreover, improved pricing in its fumed metal oxides business is expected to support margins in the fiscal first quarter.
The company should also benefit from the acquisition of Shenzhen Sanshun Nano New Materials. The acquisition significantly bolsters the market position and formulation capabilities of Cabot in the high-growth batteries market, especially in China. The buyout is also expected to create opportunities to expand Cabot’s position in the rapidly growing energy storage market.
Cabot Corporation Price and Consensus
Cabot Corporation price-consensus-chart | Cabot Corporation Quote
Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include BHP Group (BHP - Free Report) , Silvercorp Metals Inc. (SVM - Free Report) and Pretium Resources Inc. .
BHP Group has a projected earnings growth rate of 31.3% for the current fiscal year. The company’s shares have gained around 8% in a year. It currently sports a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Silvercorp has an expected earnings growth rate of 40% for the current fiscal. The company’s shares have gained around 18% in the past year. It currently carries a Zacks Rank #2.
Pretium Resources has an expected earnings growth rate of 25.5% for the current year. The company’s shares have gained around 10% in the past year. It currently carries a Zacks Rank #2.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>